MedPath

黑龙江羽迪药业有限责任公司

Ownership
-
Established
2022-08-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

Vitamin B1 Injection

Product Name
维生素B1注射液
Approval Number
国药准字H23020857
Approval Date
Jan 31, 2023
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H23021817
Approval Date
Jan 31, 2023
NMPA

麻杏止咳糖浆

Approval Number
国药准字Z23020812
Approval Date
Jan 31, 2023
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H23021847
Approval Date
Jan 31, 2023
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H23022041
Approval Date
Jan 31, 2023
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H23022040
Approval Date
Jan 31, 2023
NMPA

Inosine Injection

Product Name
肌苷注射液
Approval Number
国药准字H23020874
Approval Date
Jan 31, 2023
NMPA

Aciclovir and Glucose Injection

Product Name
阿昔洛韦葡萄糖注射液
Approval Number
国药准字H20031273
Approval Date
Jan 31, 2023
NMPA

Dextran 70 and Glucose Injection

Product Name
右旋糖酐70葡萄糖注射液
Approval Number
国药准字H23020878
Approval Date
Jan 31, 2023
NMPA

香丹注射液

Approval Number
国药准字Z23020815
Approval Date
Jan 31, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy